open access

Vol 64, No 5 (2013)
Original papers
Published online: 2013-11-01
Submitted: 2013-11-04
Accepted: 2013-11-04
Get Citation

Parathyroid gland function after radioiodine (131I) therapy for toxic and non-toxic goitre

Piotr Szumowski, Saeid Abdelrazek, Małgorzata Mojsak, Franciszek Rogowski, Agnieszka Kociura-Sawicka, Janusz Myśliwiec
DOI: 10.5603/EP.2013.0015
·
Endokrynologia Polska 2013;64(5):340-345.

open access

Vol 64, No 5 (2013)
Original papers
Published online: 2013-11-01
Submitted: 2013-11-04
Accepted: 2013-11-04

Abstract

Introduction: The therapeutic effect of radioactive iodine (131I) on benign goitre consists of the emission of tissue-destructive beta-radiation. Since the range of beta 131I radiation in tissue can reach 2.4 mm, it can affect the adjacent parathyroid glands. The purpose of this paper
is to assess parathyroid function in patients with toxic and non-toxic goitres, up to five years following 131I therapy.

Material and methods: The study sample consisted of 325 patients with benign goitres (220 with toxic nodular goitre (TNG), 25 with
non-toxic nodular goitre (NTNG), and 80 with Graves’ disease (GD) treated with 131I. The therapeutic activity of 131I for each patient was
calculated using Marinelli’s formula. The serum levels of fT3, fT4, TSH, iPTH and Ca2+, Ca and phosphates were determined one week before
131I administration, as well as every two months up to a year following the therapy, and then after three and five years post-treatment.

Results: After two months following the administration of 131I, all the treated patients showed a statistically significant above normal increase in iPTH concentrations (amounting to a value almost twice the norm in patients with TNG), which remained stable up to ten months after treatment, to return to normal level in the following months. In all the patients, Ca2+, Ca, phosphates concentration remained within normal range throughout the course of the study. The concentrations of fT3 and fT4 quickly returned to normal after 131I administration, and remained within normal range until the completion of the study.

Conclusion: Radioiodine treatment of benign thyroid disorders results in transient (up to ten months after 131I administration) hyperparathyroidism.
The condition does not influence the level of calcium and phosphates concentration in any significant way.

(Endokrynol Pol 2013; 64 (5): 340–345)

Abstract

Introduction: The therapeutic effect of radioactive iodine (131I) on benign goitre consists of the emission of tissue-destructive beta-radiation. Since the range of beta 131I radiation in tissue can reach 2.4 mm, it can affect the adjacent parathyroid glands. The purpose of this paper
is to assess parathyroid function in patients with toxic and non-toxic goitres, up to five years following 131I therapy.

Material and methods: The study sample consisted of 325 patients with benign goitres (220 with toxic nodular goitre (TNG), 25 with
non-toxic nodular goitre (NTNG), and 80 with Graves’ disease (GD) treated with 131I. The therapeutic activity of 131I for each patient was
calculated using Marinelli’s formula. The serum levels of fT3, fT4, TSH, iPTH and Ca2+, Ca and phosphates were determined one week before
131I administration, as well as every two months up to a year following the therapy, and then after three and five years post-treatment.

Results: After two months following the administration of 131I, all the treated patients showed a statistically significant above normal increase in iPTH concentrations (amounting to a value almost twice the norm in patients with TNG), which remained stable up to ten months after treatment, to return to normal level in the following months. In all the patients, Ca2+, Ca, phosphates concentration remained within normal range throughout the course of the study. The concentrations of fT3 and fT4 quickly returned to normal after 131I administration, and remained within normal range until the completion of the study.

Conclusion: Radioiodine treatment of benign thyroid disorders results in transient (up to ten months after 131I administration) hyperparathyroidism.
The condition does not influence the level of calcium and phosphates concentration in any significant way.

(Endokrynol Pol 2013; 64 (5): 340–345)

Full Text:

View HTML
Get Citation

Keywords

hyperparathyroidism; hyperthyroidism; radioiodine therapy

About this article
Title

Parathyroid gland function after radioiodine (131I) therapy for toxic and non-toxic goitre

Journal

Endokrynologia Polska

Issue

Vol 64, No 5 (2013)

Pages

340-345

Published online

2013-11-01

DOI

10.5603/EP.2013.0015

Bibliographic record

Endokrynologia Polska 2013;64(5):340-345.

Keywords

hyperparathyroidism
hyperthyroidism
radioiodine therapy

Authors

Piotr Szumowski
Saeid Abdelrazek
Małgorzata Mojsak
Franciszek Rogowski
Agnieszka Kociura-Sawicka
Janusz Myśliwiec

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl